Of note, it was shown that apigenin exerted anti-obesity effects in vitro by reducing SREBP1 levels and in obese mice by decreasing the levels of total cholesterol and of the transcription factor PPAR-γ [91,92]. Here, SREBF1 is linked to obesity disorder.